LENSAR, Inc. (LNSR) vs Sera Prognostics, Inc. (SERA)
LENSAR, Inc. and Sera Prognostics, Inc. are both Medical Devices companies. LENSAR, Inc. and Sera Prognostics, Inc. are of similar size ($86.9M and $83.2M). Sera Prognostics, Inc. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 2.4×. LENSAR, Inc. grew revenue faster over the last twelve months: 3.26% against −35.2%. LENSAR, Inc. has the higher net margin (57.6% vs −47,475.7%) and the lower return on invested capital (−379.0% vs −180.2%). Across the 17 metrics below, LENSAR, Inc. leads on 12 and Sera Prognostics, Inc. on 5.
Valuation
Profitability
| Metric | LNSR | SERA | Medical Devices median |
|---|---|---|---|
| Gross margin | 48.34% | (150.00%) | 56.01% |
| Operating margin | (13.48%) | (53,282.86%) | (15.03%) |
| Net margin | 57.57% | (47,475.71%) | (20.40%) |
| Free cash flow margin | (12.29%) | (40,760.00%) | (7.24%) |
| Return on equity | (851.75%) | (45.03%) | (15.32%) |
| Return on assets | 49.58% | (33.47%) | (19.72%) |
| Return on invested capital | (379.01%) | (180.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack